Tilray Brands' strong cannabis sales and upbeat outlook keeps Jefferies analysts bullishProactive Investors • 04/02/26
Tilray Sinks 4%: 3 Reasons the Market Isn't Impressed Despite Record Q3 Revenue24/7 Wall Street • 04/01/26
Tilray Brands, Inc. (TLRY) Reports Q3 Loss, Beats Revenue EstimatesZacks Investment Research • 04/01/26
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-YearGlobeNewsWire • 04/01/26
Tilray Brands Announces Partnership with Popsicle® to Launch Popsicle Adult BeveragesGlobeNewsWire • 03/26/26
Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026GlobeNewsWire • 03/25/26
Craft beer BrewDog to launch in Hamptons after Tilray CEO buys troubled brewerNew York Post • 03/24/26
Tilray Medical Announces Major Expansion of Medical Cannabis Portfolio in AustraliaGlobeNewsWire • 03/19/26
Breckenridge Distillery Expands Its Colorado Presence with Cheba Hut PartnershipGlobeNewsWire • 03/18/26
Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with “gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across GermanyGlobeNewsWire • 03/12/26
Canadian Cannabis Stocks to Watch in March 2026 as Global Legalization ExpandsMarijuanaStocks • 03/10/26
Tilray Brands Expects to Generate $1.2 Billion in Revenue Next Year, and It's Not the Way Investors Might Have ExpectedThe Motley Fool • 03/09/26